We focus on early-stage, research-driven medtech innovation with the potential to deliver transformative clinical impact and strong investor value.
We're looking for deeptech medtech companies in early stages where our sweet spot is early stage companies at TRL (Technology Readiness Level) between 3-5. We want to become a launchpad for medtech breakthroughs to become category leaders or strategic acquisition targets. We believe in long-term ownership, with an in-built active de-risking focus.
Our aim is to build a diversified portfolio of early-stage innovative medtech-companies where active involvement materially increases company value at key inflection points.
By strategically combining expertise in deeptech, regulatory affiars, investor readiness, go-to market and PR & brand building, we believe we maximize both patient benefit and your company growth.
